CA1165242A - Compose alcalin comprime et moule pouvant etre utilise dans les produits d'acide acetylsalicylique tamponnes - Google Patents

Compose alcalin comprime et moule pouvant etre utilise dans les produits d'acide acetylsalicylique tamponnes

Info

Publication number
CA1165242A
CA1165242A CA000383212A CA383212A CA1165242A CA 1165242 A CA1165242 A CA 1165242A CA 000383212 A CA000383212 A CA 000383212A CA 383212 A CA383212 A CA 383212A CA 1165242 A CA1165242 A CA 1165242A
Authority
CA
Canada
Prior art keywords
alkaline
magnesium
component
compressed
alkaline component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000383212A
Other languages
English (en)
Inventor
Hovsep Simonian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of CA1165242A publication Critical patent/CA1165242A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA000383212A 1981-07-01 1981-08-05 Compose alcalin comprime et moule pouvant etre utilise dans les produits d'acide acetylsalicylique tamponnes Expired CA1165242A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27801181A 1981-07-01 1981-07-01
US278,011 1981-07-01

Publications (1)

Publication Number Publication Date
CA1165242A true CA1165242A (fr) 1984-04-10

Family

ID=23063318

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000383212A Expired CA1165242A (fr) 1981-07-01 1981-08-05 Compose alcalin comprime et moule pouvant etre utilise dans les produits d'acide acetylsalicylique tamponnes

Country Status (9)

Country Link
JP (1) JPS588020A (fr)
KR (1) KR880001933B1 (fr)
AU (1) AU551510B2 (fr)
BE (1) BE893729A (fr)
CA (1) CA1165242A (fr)
GR (1) GR75990B (fr)
NZ (1) NZ200695A (fr)
PH (1) PH18787A (fr)
PT (1) PT75168B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030162B2 (en) 1996-11-12 2006-04-18 Pozen Inc. Treatment of migraine headache

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4102629A1 (de) * 1991-01-30 1992-08-06 Bayer Ag Pharmazeutischer kaugummi mit acetylsalicylsaeure
FR2708853A1 (fr) * 1993-06-30 1995-02-17 Salsarulo Gilles Composition à base d'acide acétylsalicylique à biodisponibilité améliorée et procédé pour la produire.
US5498426A (en) * 1994-10-03 1996-03-12 The Procter & Gamble Company Liquid antacid compositions
UA95093C2 (uk) * 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
JP5663238B2 (ja) * 2009-08-31 2015-02-04 ライオン株式会社 内服固形製剤及びその製造方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030162B2 (en) 1996-11-12 2006-04-18 Pozen Inc. Treatment of migraine headache

Also Published As

Publication number Publication date
PT75168A (en) 1982-07-01
NZ200695A (en) 1985-02-28
KR880001933B1 (ko) 1988-10-04
PH18787A (en) 1985-09-25
JPS588020A (ja) 1983-01-18
BE893729A (fr) 1983-01-03
AU8410982A (en) 1983-01-06
GR75990B (fr) 1984-08-03
KR840000239A (ko) 1984-02-18
PT75168B (en) 1985-06-28
AU551510B2 (en) 1986-05-01
JPH0244286B2 (fr) 1990-10-03

Similar Documents

Publication Publication Date Title
US4664915A (en) Compressed and formed alkaline component suitable for use in buffered aspirin product
CA1156554A (fr) Capsule analgesique alcaline
CA1144861A (fr) Capsule analgesique alcaline
AU636810B2 (en) Delivery system for enhanced onset and increased potency
CA2299231C (fr) Tablette comprimee de nitroglycerine et son procede de fabrication
CA1073358A (fr) Formulations a liberation prolongee
US3148124A (en) Method of preparing sustained release pharmaceutical tablets
BG65007B1 (bg) Мигновено топяща се орална дозирана форма
JPH0830007B2 (ja) 徐放性カプセル
IE61692B1 (en) Pharmaceutical compositions
LV10182B (en) Memantine-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof
US10258562B2 (en) Effervescent tablet containing high level of aspirin
US5087454A (en) Ibuprofen tablet
US4601895A (en) Delayed-action acetylsalicylic acid formulations for oral administration
AU2004255466A1 (en) Pharmaceutical formulation comprising levothyroxine sodium
CA1165242A (fr) Compose alcalin comprime et moule pouvant etre utilise dans les produits d'acide acetylsalicylique tamponnes
EP1353650A2 (fr) Procede pour la preparation d'une composition de valproate de sodium non hygroscopique
JP3292674B2 (ja) カルシウム補給剤
JPH10236959A (ja) 制酸剤含有組成物
AU2002241960A1 (en) Process for preparing non-hygroscopic sodium valproate composition

Legal Events

Date Code Title Description
MKEX Expiry